Cargando…
NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB
Progestin is one of the main hormone treatment regimens for early-stage estrogen receptor- and progesterone receptor (PR)-positive endometrial cancer (EC). However, the response rate of EC to progestins is unsatisfactory. Investigating the mechanisms related to progestin treatment could help improve...
Autores principales: | Cheng, Yali, Xie, Liying, Xu, Zhiying, Hao, Mengxin, Yang, Bingyi, Shan, Weiwei, Wang, Yiqin, Lv, Qiaoying, Chen, Xiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576598/ https://www.ncbi.nlm.nih.gov/pubmed/35388173 http://dx.doi.org/10.1038/s41417-022-00467-0 |
Ejemplares similares
-
Cataracts and NrCAM
por: Dove, Alan W.
Publicado: (2001) -
Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021) -
Neurofascin induces neurites by heterophilic interactions with axonal
NrCAM while NrCAM requires F11 on the axonal surface to extend
neurites
Publicado: (1996) -
NrCAM modulates sonic hedgehog signalling by controlling smoothened translocation in the cilium
por: Basu, B, et al.
Publicado: (2015) -
CHL1 and NrCAM are Primarily Expressed in Low Grade Pediatric Neuroblastoma
por: Wachowiak, Robin, et al.
Publicado: (2019)